These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
798 related items for PubMed ID: 25634667
1. What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient? Lee HM, Archer JR, Dargan PI, Wood DM. Clin Toxicol (Phila); 2015 Mar; 53(3):145-50. PubMed ID: 25634667 [Abstract] [Full Text] [Related]
3. Comparison of methods for intravenous infusion of fat emulsion during extracorporeal membrane oxygenation. Buck ML, Wooldridge P, Ksenich RA. Pharmacotherapy; 2005 Nov; 25(11):1536-40. PubMed ID: 16232016 [Abstract] [Full Text] [Related]
4. Extracorporeal membrane oxygenation in the treatment of poisoned patients. de Lange DW, Sikma MA, Meulenbelt J. Clin Toxicol (Phila); 2013 Jun; 51(5):385-93. PubMed ID: 23697460 [Abstract] [Full Text] [Related]
5. Extracorporeal membrane oxygenation use in poisoning: a narrative review with clinical recommendations. Upchurch C, Blumenberg A, Brodie D, MacLaren G, Zakhary B, Hendrickson RG. Clin Toxicol (Phila); 2021 Oct; 59(10):877-887. PubMed ID: 34396873 [Abstract] [Full Text] [Related]
6. Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report. Yu K, Long C, Hei F, Li J, Liu J, Ji B, Gao G, Zhang H, Song Y, Wang W. Artif Organs; 2011 Jul; 35(7):733-7. PubMed ID: 21375546 [Abstract] [Full Text] [Related]
7. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry. Weiner L, Mazzeffi MA, Hines EQ, Gordon D, Herr DL, Kim HK. Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764 [Abstract] [Full Text] [Related]
8. Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation. Khalid N, Javed H, Ahmad SA, Edelman JJ, Shlofmitz E, Chen Y, Musallam A, Rogers T, Hashim H, Bernardo NL, Waksman R. Cardiovasc Revasc Med; 2020 Feb; 21(2):230-234. PubMed ID: 31767523 [Abstract] [Full Text] [Related]
10. Treatment for beta-blocker poisoning: a systematic review. Rotella JA, Greene SL, Koutsogiannis Z, Graudins A, Hung Leang Y, Kuan K, Baxter H, Bourke E, Wong A. Clin Toxicol (Phila); 2020 Oct; 58(10):943-983. PubMed ID: 32310006 [Abstract] [Full Text] [Related]
11. Intravenous lipid emulsion to reverse acute drug toxicity in pediatric patients. Presley JD, Chyka PA. Ann Pharmacother; 2013 May; 47(5):735-43. PubMed ID: 23613099 [Abstract] [Full Text] [Related]
12. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors. Loforte A, Marinelli G, Musumeci F, Folesani G, Pilato E, Martin Suarez S, Montalto A, Lilla Della Monica P, Grigioni F, Frascaroli G, Menichetti A, Di Bartolomeo R, Arpesella G. Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637 [Abstract] [Full Text] [Related]
13. Utilization of lipid emulsion therapy in fatal overdose cases: an observational study. Smolinske S, Hoffman RS, Villeneuve E, Hoegberg LCG, Gosselin S. Clin Toxicol (Phila); 2019 Mar; 57(3):197-202. PubMed ID: 30260247 [Abstract] [Full Text] [Related]